dexamethasone sustained-release (TLC599) / Taiwan Liposome Company, Endo  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dexamethasone sustained-release (TLC599) / Taiwan Liposome Company, Endo
ChiCTR2200063155: Anti-VEGF Drugs and Dexamethasone Extended-Release Implant (Ozurdex) for Diabetic Macular Edema

Recruiting
N/A
60
 
Intravitreal injection of anti-VEGF drugs ;Intravitreal injection of dexamethasone sustained-release implant
The Second Hospital of Dalian Medical University; The Second Hospital of Dalian Medical University, self-funded
Diabetic Macular Edema
 
 

Download Options